Evidence map›Paper›PMID 37929634›Full record

ArticleAmerican journal of hematology2024

Phenotypic and proteomic characterization of the human erythroid progenitor continuum reveal dynamic changes in cell cycle and in metabolic pathways.

Julien Papoin, Hongxia Yan, Marjorie Leduc, Morgane Le Gall, Anupama Narla, James Palis, Laurie A Steiner, Patrick G Gallagher, Christopher D Hillyer, Emilie-Fleur Gautier and 2 more

Open access · hybridAbstract read
In one paragraph

Article in American journal of hematology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Julien PapoinInstitute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.ORCID 0000-0002-5446-6469
Hongxia YanRed Cell Physiology Laboratory, Lindsey F. Kimball Research Institute, New York Blood Center, New York, New York, USA.
Marjorie LeducProteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.
Morgane Le GallProteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.
Anupama NarlaDivision of Hematology-Oncology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
James PalisCenter for Child Health Research, University of Rochester, Rochester, New York, USA.
Laurie A SteinerCenter for Child Health Research, University of Rochester, Rochester, New York, USA.
Patrick G GallagherDepartment of Pediatrics, Yale University, New Haven, Connecticut, USA.
Christopher D HillyerRed Cell Physiology Laboratory, Lindsey F. Kimball Research Institute, New York Blood Center, New York, New York, USA.
Emilie-Fleur GautierProteom'IC facility, Université Paris Cité, CNRS, INSERM, Institut Cochin, Paris, France.ORCID 0000-0002-0394-6606
Narla MohandasRed Cell Physiology Laboratory, Lindsey F. Kimball Research Institute, New York Blood Center, New York, New York, USA.ORCID 0000-0003-2271-5296
Lionel BlancInstitute of Molecular Medicine, Feinstein Institutes for Medical Research, Manhasset, New York, USA.ORCID 0000-0002-0185-6260
Centre National de la Recherche Scientifique · FRNew York Blood Center · USFeinstein Institute for Medical Research · USUniversity of Rochester · USNationwide Children's Hospital · USPalo Alto University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
YEAST MEMBRANE CYTOSKELETONP01DK032094 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1987 to 2021
$26.7M
Molecular targeting of erythroid progenitor cells in normal and disordered human erythropoiesisR01HL144436 · NHLBI · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI BLANC, LIONEL · 2019 to 2023
$2.5M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS HL144436NHLBI NIH HHS R01 HL144436NIDDK NIH HHS DK32094NIDDK NIH HHS P01 DK032094
6 · The paper itself

Abstract

Human erythropoiesis is a complex process leading to the production of 2.5 million red blood cells per second. Following commitment of hematopoietic stem cells to the erythroid lineage, this process can be divided into three distinct stages: erythroid progenitor differentiation, terminal erythropoiesis, and reticulocyte maturation. We recently resolved the heterogeneity of erythroid progenitors into four different subpopulations termed EP1-EP4. Here, we characterized the growth factor(s) responsiveness of these four progenitor populations in terms of proliferation and differentiation. Using mass spectrometry-based proteomics on sorted erythroid progenitors, we quantified the absolute expression of ~5500 proteins from EP1 to EP4. Further functional analyses highlighted dynamic changes in cell cycle in these populations with an acceleration of the cell cycle during erythroid progenitor differentiation. The finding that E2F4 expression was increased from EP1 to EP4 is consistent with the noted changes in cell cycle. Finally, our proteomic data suggest that the protein machinery necessary for both oxidative phosphorylation and glycolysis is present in these progenitor cells. Together, our data provide comprehensive insights into growth factor-dependence of erythroid progenitor proliferation and the proteome of four distinct populations of human erythroid progenitors which will be a useful framework for the study of erythroid disorders.

Indexed as

Hematopoietic Stem CellsProteomicsCell CycleCell DifferentiationErythroid Precursor CellsErythropoiesisHumansIntercellular Signaling Peptides and ProteinsMetabolic Networks and PathwaysIntercellular Signaling Peptides and Proteins

Identifiers

PMID37929634
PMCPMC10877306
OpenAlexW4388413994

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.